BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37420326)

  • 1. A Trojan-Horse-Like Biomimetic Nano-NK to Elicit an Immunostimulatory Tumor Microenvironment for Enhanced GBM Chemo-Immunotherapy.
    Zhang L; Zhang Y; Wang X; Zhou Y; Qi J; Gu L; Zhao Q; Yu R; Zhou X
    Small; 2023 Nov; 19(44):e2301439. PubMed ID: 37420326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomimetic calcium carbonate nanoparticles delivered IL-12 mRNA for targeted glioblastoma sono-immunotherapy by ultrasound-induced necroptosis.
    Zhao P; Tian Y; Lu Y; Zhang J; Tao A; Xiang G; Liu Y
    J Nanobiotechnology; 2022 Dec; 20(1):525. PubMed ID: 36496387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR4-targeted nitric oxide nanoparticles deliver PD-L1 siRNA for immunotherapy against glioblastoma.
    Hsieh HT; Huang HC; Chung CW; Chiang CC; Hsia T; Wu HF; Huang RL; Chiang CS; Wang J; Lu TT; Chen Y
    J Control Release; 2022 Dec; 352():920-930. PubMed ID: 36334859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain Co-Delivery of Temozolomide and Cisplatin for Combinatorial Glioblastoma Chemotherapy.
    Zou Y; Wang Y; Xu S; Liu Y; Yin J; Lovejoy DB; Zheng M; Liang XJ; Park JB; Efremov YM; Ulasov I; Shi B
    Adv Mater; 2022 Aug; 34(33):e2203958. PubMed ID: 35738390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Density Lipoprotein-Mimicking Nanodiscs for Chemo-immunotherapy against Glioblastoma Multiforme.
    Kadiyala P; Li D; Nuñez FM; Altshuler D; Doherty R; Kuai R; Yu M; Kamran N; Edwards M; Moon JJ; Lowenstein PR; Castro MG; Schwendeman A
    ACS Nano; 2019 Feb; 13(2):1365-1384. PubMed ID: 30721028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.
    Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X
    Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimuli-Responsive Multifunctional Nanomedicine for Enhanced Glioblastoma Chemotherapy Augments Multistage Blood-to-Brain Trafficking and Tumor Targeting.
    Martins C; Araújo M; Malfanti A; Pacheco C; Smith SJ; Ucakar B; Rahman R; Aylott JW; Préat V; Sarmento B
    Small; 2023 Jun; 19(22):e2300029. PubMed ID: 36852650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced Caspase-Mediated Abrogation of Autophagy by Temozolomide-Loaded and Panitumumab-Conjugated Poly(lactic-
    Banstola A; Duwa R; Emami F; Jeong JH; Yook S
    Mol Pharm; 2020 Nov; 17(11):4386-4400. PubMed ID: 33079558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain-targeted antigen-generating nanoparticles improve glioblastoma prognosis.
    Wang W; Zhang M; Zhang Q; Mohammadniaei M; Shen J; Sun Y
    J Control Release; 2022 Dec; 352():399-410. PubMed ID: 36309097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nano-Codelivery of Temozolomide and siPD-L1 to Reprogram the Drug-Resistant and Immunosuppressive Microenvironment in Orthotopic Glioblastoma.
    Liu D; Cheng Y; Qiao S; Liu M; Ji Q; Zhang BL; Mei QB; Zhou S
    ACS Nano; 2022 May; 16(5):7409-7427. PubMed ID: 35549164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IRGD-modified erythrocyte membrane biomimetic temozolomide nanodots for the treatment of glioblastoma.
    Luo D; Chen Z; Peng Y; Liu C
    Nanotechnology; 2024 Mar; 35(24):. PubMed ID: 38408368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma.
    Kim SS; Rait A; Kim E; DeMarco J; Pirollo KF; Chang EH
    Cancer Lett; 2015 Dec; 369(1):250-8. PubMed ID: 26325605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomimetic Dp44mT-nanoparticles selectively induce apoptosis in Cu-loaded glioblastoma resulting in potent growth inhibition.
    Ismail M; Yang W; Li Y; Wang Y; He W; Wang J; Muhammad P; Chaston TB; Rehman FU; Zheng M; Lovejoy DB; Shi B
    Biomaterials; 2022 Oct; 289():121760. PubMed ID: 36044788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversing T Cell Dysfunction to Boost Glioblastoma Immunotherapy by Paroxetine-Mediated GRK2 Inhibition and Blockade of Multiple Checkpoints through Biomimetic Nanoparticles.
    Wang T; Zhang H; Han Y; Zheng Q; Liu H; Han M; Li Z
    Adv Sci (Weinh); 2023 Mar; 10(9):e2204961. PubMed ID: 36698265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoattractants driven and microglia based biomimetic nanoparticle treating TMZ-resistant glioblastoma multiforme.
    Qiao S; Cheng Y; Liu M; Ji Q; Zhang B; Mei Q; Liu D; Zhou S
    J Control Release; 2021 Aug; 336():54-70. PubMed ID: 34129862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple Synergistic Effects of the Microglia Membrane-Bionic Nanoplatform on Mediate Tumor Microenvironment Remodeling to Amplify Glioblastoma Immunotherapy.
    Fan Q; Kuang L; Wang B; Yin Y; Dong Z; Tian N; Wang J; Yin T; Wang Y
    ACS Nano; 2024 Jun; 18(22):14469-14486. PubMed ID: 38770948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor microenvironment-responsive versatile "Trojan horse" theranostic nanoplatform for magnetic resonance imaging-guided multimodal synergistic antitumor treatment.
    Huang Q; Pan Y; Wang M; Liu Z; Chen H; Wang J; Zhao Z; Zhang Y
    Acta Biomater; 2022 Jul; 147():270-286. PubMed ID: 35595202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme.
    Li Z; Zhang J; Zheng H; Li C; Xiong J; Wang W; Bao H; Jin H; Liang P
    J Exp Clin Cancer Res; 2019 Aug; 38(1):380. PubMed ID: 31462285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting.
    Wang L; Tang S; Yu Y; Lv Y; Wang A; Yan X; Li N; Sha C; Sun K; Li Y
    Mol Pharm; 2021 Mar; 18(3):915-927. PubMed ID: 33417456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
    Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y
    Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.